Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston blog main
boston top stories
glaxosmithkline
7
×
life sciences
national blog main
national top stories
raleigh-durham blog main
raleigh-durham top stories
7
×
san francisco blog main
startups
7
×
boulder/denver blog main
boulder/denver top stories
detroit blog main
detroit top stories
indiana blog main
indiana top stories
national
new york blog main
new york top stories
san diego blog main
san diego top stories
san francisco top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
clinical trials
deals
alzheimer's disease
amgen
cancer
cancer immunotherapy
eli lilly
fda
merck
abbvie
biogen
What
roundup
bio
drug
alliance
black
companies
crispr
diamond’s
disease
earlier
nash
new
news
according
acquisitions
adds
akcea
albert
appetite
approval
areas
biggest
biogen’s
biopharmaceutical
biosciences
biotech
bio’s
bourla
bread
brii
bristol
butter
buy
buyout
calls
cancer
cases
cash
centers
ceo
Language
unset
unknown
Current search:
glaxosmithkline
×
startups
×
" raleigh-durham top stories "
×
@xconomy.com
3 years ago
Bio Roundup: CRISPR Kudos, Bristol Myers’s Buy, RNAi Alliance & More
@xconomy.com
4 years ago
Bio Roundup: Mammoth Moves, Black Diamond’s Pop, Ohana’s Debut & More
@xconomy.com
4 years ago
Biotech Roundup: Vaping Toll Rises, NASH News, Akcea Shakeup & More
@xconomy.com
4 years ago
Bio Roundup: Pfizer’s Future, CRISPR in Patients, Drug Imports & More
@xconomy.com
5 years ago
Bio Roundup: Biogen’s Strategy, Drug Price Convo, NASH News & More
@xconomy.com
5 years ago
Bio Roundup: #JPM19 Notes, Loxo Buyout, Black Diamond’s Cash & More
@xconomy.com
5 years ago
Brii Bio’s Alliance with VBI Vaccines Adds Hepatitis B Drug to Pipeline